RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 AMM Benefits Those Who Fail Antithrombotic Therapy
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 1
SP 14
OP 15
DO 10.1177/155989771201006
UL http://mdc.sagepub.com/content/12/1/14.abstract
AB As landmark trials have shown no outcome improvement with vascular bypass or percutaneous angioplasty and stenting, aggressive medical management remains the gold standard for symptomatic intracranial artery disease [Augoustides JG. J Cardiothorac Vasc Anesth 2012]. This article presented outcomes of patients in the SAMMPRIS trial who had failed antithrombotic therapy at study enrollment.